Trial site
Spitalul Clinic Judetean de Urgenta Targu Mures
- 42running trials
- 14closed trials
The trials here
What the 56 trials at this site are about, from their registry records.
- Conditions
- High blood pressure9 trials
- Heart failure7 trials
- Pulmonary arterial hypertension5 trials
- Atrial fibrillation4 trials
- Multiple sclerosis4 trials
- Stroke4 trials
- Chronic kidney disease3 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)3 trials
- Epilepsy3 trials
- Myasthenia gravis3 trials
- Myeloproliferative neoplasms3 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- and 15 more
- Phase
- Phase 347 trials
- Phase 25 trials
- Phase 42 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting23 trials
- Active, not recruiting15 trials
- Completed13 trials
- Not yet recruiting4 trials
- Withdrawn1 trial
- Lead sponsor
- Boehringer Ingelheim4 trials
- Novo Nordisk A/S4 trials
- Immunovant Sciences GmbH3 trials
- Janssen Research & Development, LLC3 trials
- Novartis Pharmaceuticals3 trials
- and 32 more
Running trials
Recruiting
Recruiting
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Recruiting
Recruiting
Active, not recruiting
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Recruiting
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Recruiting
Recruiting
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Enrolling by invitation
Recruiting
Recruiting
Active, not recruiting
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Active, not recruiting
Active, not recruiting
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Recruiting
Active, not recruiting
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure5 recruiting
- High blood pressure5 recruiting
- Pulmonary arterial hypertension3 recruiting
- Stroke3 recruiting
- Atrial fibrillation2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Myasthenia gravis2 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Cushing's syndrome1 recruiting
- Epilepsy1 recruiting
- Huntington's disease1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Multiple sclerosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Primary biliary cholangitis1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Recruiting
Completed
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Active, not recruiting
Completed
Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP.
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
Completed
Completed
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Completed
Acute-On-Chronic Liver Failure (ACLF) at High Risk of Hospital Mortality
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026